id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2013-N-0242-0009,FDA,FDA-2013-N-0242,"Agency Information Collection Activities; Proposals, Submissions, and Approvals: Announcement of Office of Management and Budget Approvals",Notice,Notice of Approval,2016-12-19T05:00:00Z,2016,12,2016-12-19T05:00:00Z,,2016-12-19T15:46:13Z,2016-30351,0,0,09000064824264d1
FDA-2013-N-0242-0008,FDA,FDA-2013-N-0242,Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Current Good Manufacturing Practice for Positron Emission Tomography Drugs,Notice,30 Day Proposed Information Collection,2016-07-11T04:00:00Z,2016,7,2016-07-11T04:00:00Z,2016-08-11T03:59:59Z,2016-07-11T15:30:51Z,2016-16360,0,0,090000648209bdc7